Evidence map›Paper›PMID 24520172›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+ T cells.

John A Altin, Stephen R Daley, Jason Howitt, Helen J Rickards, Alison K Batkin, Keisuke Horikawa, Simon J Prasad, Keats A Nelms, Sharad Kumar, Lawren C Wu and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The CD8Immunity · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

John A AltinJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Stephen R Daley
Jason Howitt
Helen J Rickards
Alison K Batkin
Keisuke Horikawa
Simon J Prasad
Keats A Nelms
Sharad Kumar
Lawren C Wu
Seong-Seng Tan
Matthew C Cook
Christopher C Goodnow
Australian National University · AUFlorey Institute of Neuroscience and Mental Health · AUGenentechUniversity of South Australia · AU

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Systems Approach to Innate Immunity-Inflammation-SepsisU54AI054523 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2002 to 2006
$28.0M
NIAID NIH HHS AI054523NIAID NIH HHS AI100627NIAID NIH HHS U19 AI100627NIAID NIH HHS U54 AI054523Wellcome Trust 082030/B/07/Z
6 · The paper itself

Abstract

The NDFIP1 (neural precursor cell expressed, developmentally down-regulated protein 4 family-interacting protein 1) adapter for the ubiquitin ligase ITCH is genetically linked to human allergic and autoimmune disease, but the cellular mechanism by which these proteins enable foreign and self-antigens to be tolerated is unresolved. Here, we use two unique mouse strains--an Ndfip1-YFP reporter and an Ndfip1-deficient strain--to show that Ndfip1 is progressively induced during T-cell differentiation and activation in vivo and that its deficiency causes a cell-autonomous, Forkhead box P3-independent failure of peripheral CD4(+) T-cell tolerance to self and exogenous antigen. In small cohorts of antigen-specific CD4(+) cells responding in vivo, Ndfip1 was necessary for tolerogen-reactive T cells to exit cell cycle after one to five divisions and to abort Th2 effector differentiation, defining a step in peripheral tolerance that provides insights into the phenomenon of T-cell anergy in vivo and is distinct from the better understood process of Bcl2-interacting mediator of cell death-mediated apoptosis. Ndfip1 deficiency precipitated autoimmune pancreatic destruction and diabetes; however, this depended on a further accumulation of nontolerant anti-self T cells from strong stimulation by exogenous tolerogen. These findings illuminate a peripheral tolerance checkpoint that aborts T-cell clonal expansion against allergens and autoantigens and demonstrate how hypersensitive responses to environmental antigens may trigger autoimmunity.

Indexed as

Adaptation, PhysiologicalCell CycleAnimalsCarrier ProteinsCD4-Positive T-LymphocytesCell DifferentiationCell ProliferationForkhead Transcription FactorsIntercellular Signaling Peptides and ProteinsLymphocyte ActivationMembrane ProteinsMiceMice, Inbred C57BLCarrier ProteinsForkhead Transcription FactorsFoxp3 protein, mouseIntercellular Signaling Peptides and ProteinsMembrane ProteinsNdfip1 protein, mouseAire (Autoimmune Regulator)allergyimmunological toleranceInterleukin-4T lymphocyte

Identifiers

PMID24520172
PMCPMC3926078
OpenAlexW2138225895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.